• The New Obesity Drugs: What Cardiac Practitioners Need to Know

  • Mar 19 2024
  • Duración: 35 m
  • Podcast

The New Obesity Drugs: What Cardiac Practitioners Need to Know Por arte de portada

The New Obesity Drugs: What Cardiac Practitioners Need to Know

Escúchala gratis

Ver detalles del espectáculo

  • Resumen


  • Please join our special guest Dr. Ian Neeland from University Hospitals in Cleveland, to discuss the intersection of obesity and cardiovascular disease, and specifically the roles of the new agents semaglutide and tirzepatide. We discuss the recent data on cardiovascular outcomes with these agents, assessing patient candidacy, and tips for initiating and monitoring therapy. We also reviewed the complementary role of bariatric surgery and pharmacotherapy to improve cardiac outcomes.

    For more information, see the SELECT study.
    For more information about the UH CINEMA program, click on this link.

    Please subscribe to receive updated episodes automatically! Visit https://www.ohioacc.org/cardiohio-podcast/.

    “Upbeat Party” by scottholmesmusic.com
    Más Menos
activate_primeday_promo_in_buybox_DT
Hygiene & Healthy Living Ciencia
Más Menos

Lo que los oyentes dicen sobre The New Obesity Drugs: What Cardiac Practitioners Need to Know

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles